Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Stereotactic depth electrode placement for chronic subthreshold cortical stimulation: surgical technique video
Harrison, Daniel , Oushy, Soliman , Harrison, Daniel Jeremiah, Oushy, Soliman H , Gregg, Nicholas M. , Lundstrom, Brian N. , Gompel, Jamie J. Van

Neurosurgical Focus: Video | July 3, 2024 | Volume: 11 | Issue: 1 | Pages: V10

10.3171/2024.4.focvid2422 | PMID 38957423 Get It

Neurostimulation is an increasingly common treatment option for medically intractable epilepsy. SANTE (Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy) and Responsive Neurostimulation (RNS) System are landmark neurostimulation trials that utilized either duty cycle or a responsive stimulation paradigm. A seizure-free outcome is rarely observed with responsive and duty cycle neurostimulation devices. Chronic subthreshold cortical stimulation (CSCS) is a promising treatment for adult drug-resistant epilepsy involving eloquent cortex and has demonstrated safety and efficacy. Herein, the authors describe the surgical technique as well as details of stimulation programming involved in CSCS placement to facilitate the adoption of this promising treatment. The video can be found here: https://stream.cadmore.media/r10.3171/2024.4.FOCVID2422
Targeting IL-1 controls refractory pityriasis rubra pilaris
Schmauch, Eloi , Severin, Yannik , Xing, Xianying , Mangold, Aaron R. , Conrad, Curdin , Johannsen, Pål, Kahlenberg, J. Michelle , Mellett, Mark , Navarini, Alexander A. , Nobbe, Stefan , Nilsson, Jakob , Linna-Kuosmanen, Suvi , Snijder, Berend , Contassot, Emmanuel , Kolios, Antonios G.A. , Mangold, A R , Johansen, Pål , Navarini, Alexander , Sarkar, Mrinal K , Satyam, Abhigyan , Tsoi, Lam C , French, Lars E , Nilsson, Jakob , Linna-Kuosmanen, Suvi , Kaikkonen, Minna U , Snijder, Berend , Kellis, Manolis , Gudjonsson, Johann E , Tsokos, George C. , Contassot, Emmanuel , Kolios, Antonios G A , Kahlenberg, J Michelle , Sarkar, Mrinal K. , Tsoi, Lam C.

Science Advances | July 3, 2024 | Volume: 10 | Issue: 27 | Pages: No page available

10.1126/sciadv.ado2365 | PMID 38959302 Get It

Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disease with a poorly understood pathogenesis. Through a molecularly driven precision medicine approach and an extensive mechanistic pathway analysis in PRP skin samples, compared to psoriasis, atopic dermatitis, healed PRP, and healthy controls, we identified IL-1β as a key mediator, orchestrating an NF-κB–mediated IL-1β–CCL20 axis, including activation of CARD14 and NOD2. Treatment of three patients with the IL-1 antagonists anakinra and canakinumab resulted in rapid clinical improvement and reversal of the PRP-associated molecular signature with a 50% improvement in skin lesions after 2 to 3 weeks. This transcriptional signature was consistent with in vitro stimulation of keratinocytes with IL-1β. With the central role of IL-1β underscoring its potential as a therapeutic target, our findings propose a redefinition of PRP as an autoinflammatory keratinization disorder. Further clinical trials are needed to validate the efficacy of IL-1β antagonists in PRP.
Signal detrending in elastographic wave data with large motion artifacts through a 2D Whittaker smoother
David, Rosen P., Alizad, Azra , Fatemi, Mostafa

The Journal of the Acoustical Society of America | July 3, 2024 | Volume: 155 | Issue: 3_Supplement | Pages: A246-A246

10.1121/10.0027381 Get It

A variety of advanced shear wave elastography techniques require the measurement of frequency-resolved phase velocity to properly characterize wave signals where factors such as tissue viscosity or guided wave effects are present. However, when applying these techniques in a dynamic environment where extrinsic motion cannot be limited, nonlinear and nonstationary trends can be expected in the motion signal used for phase velocity estimation. Because such extrinsic motion signals can contaminate a broad range of frequencies, they can produce significant errors in the phase velocity estimates. In this study, we propose a spatiotemporal detrending approach for elastography wave motion signals built from a 2D Whittaker smoother. This smoother has its origins in nonparametric regression and is well suited for fitting nonlinear curves of arbitrary shape. The resulting detrending filter was applied to Lamb wave signals from clinical ultrasound bladder vibrometry measurements. We found that the proposed detrending filter allowed for phase velocity estimates to be made in acquisitions that are otherwise be too corrupted by large motion. This works was supported by a grant from the NIH (DK131685)
Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations
Wiedmeier, Julia E. , McCabe, Chantal E. , O’Brien, Daniel R. , Jessen, Erik , Campos, Cecília Bonolo de , Waller, Rosalie G. , Allmer, Cristine, Rabe, Kari G. , Cerhan, James R. , Kay, Neil E. , Yan, Huihuang , Dyke, Daniel L. Van , Griffin, R. L. , Wiedmeier-Nutor, Julia E , Bonolo de Campos, Cecilia, Griffin, Rosalie, Chaffee, Kari G. , Cerhan, James R , Kay, Neil E , Van Dyke, Daniel L, Jessen, Erik , Waller, Rosalie G , Griffin, Rosalie , Boddicker, Nicholas , Parikh, Sameer A. , Slager, Susan L. , Braggio, Esteban

Cancers | July 3, 2024 | Volume: 16 | Issue: 13 | Pages: 2450

10.3390/cancers16132450 | PMID 39001512 Get It

Chronic lymphocytic leukemia (CLL) is characterized by multiple copy number alterations (CNAs) and somatic mutations that are central to disease prognosis, risk stratification, and mechanisms of therapy resistance. Fluorescence in situ hybridization (FISH) panels are widely used in clinical applications as the gold standard for screening prognostic chromosomal abnormalities in CLL. DNA sequencing is an alternative approach to identifying CNAs but is not an established method for clinical CNA screening. We sequenced DNA from 509 individuals with CLL or monoclonal B-cell lymphocytosis (MBL), the precursor to CLL, using a targeted sequencing panel of 59 recurrently mutated genes in CLL and additional amplicons across regions affected by clinically relevant CNAs [i.e., del(17p), del(11q), del(13q), and trisomy 12]. We used the PatternCNV algorithm to call CNA and compared the concordance of calling clinically relevant CNAs by targeted sequencing to that of FISH. We found a high accuracy of calling CNAs via sequencing compared to FISH. With FISH as the gold standard, the specificity of targeted sequencing was >95%, sensitivity was >86%, positive predictive value was >90%, and negative predictive value was >84% across the clinically relevant CNAs. Using targeted sequencing, we were also able to identify other common CLL-associated CNAs, including del(6q), del(14q), and gain 8q, as well as complex karyotype, defined as the presence of 3 or more chromosomal abnormalities, in 26 patients. In a single and cost-effective assay that can be performed on stored DNA samples, targeted sequencing can simultaneously detect CNAs, somatic mutations, and complex karyotypes, which are all important prognostic features in CLL.
Real-time 3D ultrasound imaging with a clip-on device attached to common 1D array transducers
Li, Shuangliang , Zou, Jun , Dong, Zhijie , Huang, Chengwu , Lowerison, Matthew R. , Yan, Dongliang, Wang, Yike , Chen, Shigao , Song, Pengfei

The Journal of the Acoustical Society of America | July 3, 2024 | Volume: 155 | Issue: 3_Supplement | Pages: A102-A102

10.1121/10.0026955 Get It

Performing 3D ultrasound imaging at a real-time volume rate (e.g., >20 Hz) is a challenging task. While 2D array transducers remain the most practical approach for real-time 3D imaging, the large number of transducer elements (e.g., several thousand) that are necessary to cover an effective 3D field-of-view impose a fundamental constraint on imaging speed. Although solutions such as multiplexing and specialized transducers, including sparse arrays and row-column-addressing arrays, have been developed to address this limitation, they inevitably compromise imaging quality (e.g., SNR, resolution) in favor of speed. Coupled with the high equipment cost of 2D arrays, these compromises hinder the widespread adoption of 3D ultrasound imaging technologies in clinical settings. In this presentation, we introduce an innovative transducer clip-on device comprising a water-immersible, fast-tilting electromechanical acoustic reflector and a redirecting reflector to enable real-time 3D ultrasound imaging using common 1D array transducers. We will first introduce the principles underlying our novel technique, followed by validation studies incorporating simulation and experimental data. We will also demonstrate the feasibility of using the clip-on device to achieve a high 3D imaging volume rate that is suitable for advanced imaging modes such as shear wave elastography, blood flow imaging, and super-resolution ultrasound localization microscopy.
Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Elshaer, Amani , Chascsa, David M. , Chascsa, David M , Lizaola-Mayo, Blanca C, Lizaola‐Mayo, Blanca

Life | July 3, 2024 | Volume: 14 | Issue: 7 | Pages: 844

10.3390/life14070844 | PMID 39063598 Get It

Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a liver disorder characterized by steatosis with underlying metabolic risk factors. The prevalence of MASLD continues to rise, leading to increased patient risk of various complications. Recent research has been focused on new therapeutic strategies to reduce the incidence of MASLD and provide effective treatment plans to prevent further irreversible liver damage. The treatment approach is multifactorial, with a primary focus on weight loss and management of underlying comorbidities through lifestyle modifications, pharmacotherapy, or surgical options. Ongoing research is exploring new pharmacological therapies that could enhance the treatment of MASLD.
Differences in Right Heart Function After Pulmonary Valve Replacement in Patients With Pulmonary Valve Stenosis Versus Tetralogy of Fallot
Egbe, Alexander C. , Jain, C. Charles , Abozied, Omar , Burchill, Luke J. , Younis, Ahmed , Karnakoti, Snigdha , Ahmed, Marwan H. , Connolly, Heidi M. , Burchill, Luke J , Younis, Ahmed , Ahmed, Marwan H.

Journal of the American Heart Association | July 3, 2024 | Volume: 13 | Issue: 14 | Pages: No page available

10.1161/jaha.124.034833 | PMID 38958134 Get It

Background There are limited data about the impact of timing of pulmonary valve replacement (PVR) on right heart reverse remodeling in patients with pulmonary regurgitation following intervention for isolated pulmonary valve stenosis (PS). This study compared differences in postprocedural right heart reverse remodeling after early versus late PVR (defined as PVR before versus after attainment of the conservative consensus criteria proposed by Bokma et al, 2018) in patients with prior intervention for PS, using patients with tetralogy of Fallot as the reference group. Method and Results Right atrial reservoir strain and right ventricular free wall strain was measured at baseline, 1 and 3 years after PVR. There were 114 patients with PS (early PVR, 87 [76%]; late PVR, 27 [24%]) and 291 patients with tetralogy of Fallot (early PVR, 197 [67%]; late PVR, 96 [33%]). The PS group had greater improvement in right atrial reservoir strain at 1 year (12%±4% versus 8%±4%; P <0.001) and 3 years (15%±6% versus 9%±6%; P <0.001), and a greater improvement in right ventricular free wall strain at 1 year (12%±4% versus 7%±3%, P =0.008) and 3‐years (16%±6% versus 12%±5%; P =0.01) after PVR compared with the tetralogy of Fallot group. There was no difference in right heart reverse remodeling between patients who underwent early versus later PVR within the PS group. In contrast, late PVR was associated with less right heart reverse remodeling within the tetralogy of Fallot group. Conclusions These data suggest that patients with palliated PS presenting pulmonary regurgitation have a more benign clinical course, and hence delaying PVR in this population may be appropriate.
Advances in Understanding Brain Connectivity
Whitwell, Jennifer L. , Laureys, Steven , Whitwell, Jennifer L.

Brain Connectivity | July 3, 2024 | Volume: 14 | Issue: 6 | Pages: 305-306

10.1089/brain.2024.0047 | PMID 38940729 Get It

O-110 Adenomyosis : the challenge of classification and diagnosis
Sanie, S As, Wilde, R L De, Gordts, S, Guo, S -W, Keckstein, J, Nisolle, Michelle , Johnson, NP, Grimbizis, Grigoris , Féki, Anis , Acién, Maribel , Wilde, Rudy Leon De , Guo, S -W, Keckstein, J, Laganà, Antonio Simone , Maggiore, Umberto Leone Roberti , SARIDOĞAN, Erdinç , Stewart, Elizabeth A. , Tellum, Tina , Tomassetti, Carla , Clef, Nathalie Le

Human Reproduction | July 3, 2024 | Volume: 39 | Issue: Supplement_1 | Pages: No page available

10.1093/humrep/deae108.121 Get It

Abstract Study question What does the collaborative document on adenomyosis terminology, classification, and diagnosis by ESGE, ESHRE, and WES provides? Summary answer This good practice recommendations paper offers guidance on the technical aspects, terminology, classification, and diagnosis of adenomyosis in women of reproductive age. What is known already The existing literature on adenomyosis terminology is heterogeneous and confusing. Various classification systems based on ultrasound and MRI have been proposed, yet none have gained international acceptance or clinical validation. The contradictory data on the diagnostic accuracy of these modalities further complicate adenomyosis diagnosis in reproductive-age women. Study design, size, duration A working group from ESGE, ESHRE, and WES has collaborated to write recommendations concerning the terminology, classification, and diagnosis of adenomyosis. Participants/materials, setting, methods Focusing on terminology, classification, and diagnosis, this good practice paper paves the way for further recommendations on the management and surgical treatment of adenomyosis in reproductive-age women. Main results and the role of chance The document overviews adenomyosis terminology and reviews proposed classification systems based on histology, ultrasound, and MRI, concluding with diagnostic recommendations. Limitations, reason for caution Owing the scarcity of evidence, these recommendations predominantly rely on clinical expertise. Wider implications of the findings The recommendations aim to enhance existing adenomyosis guidelines. Study funding/Competing interests All costs were covered by ESHRE funds, with no external funding for the development process or manuscript production.
O-111 Premature ovarian insufficiency: new data and updated guidance
Panay, Nicholas , Bennie, A, Cedars, Marcelle I. , Davies, Melanie , Kim, K., Rocca, Walter A. , Anderson, Richard A. , Bennie, Amy , Ee, Carolyn , Gravholt, Claus Højbjerg , Kalantaridou, Sophia , Kallen, Amanda Nicole , Misrahi, Micheline , Nappi, Rossella E , Ruan, Xiangyan , Teede, Helena , Vermeulen, Nathalie , Vogt, Elinor , Vincent, Amanda J

Human Reproduction | July 3, 2024 | Volume: 39 | Issue: Supplement_1 | Pages: No page available

10.1093/humrep/deae108.122 Get It

Abstract Premature ovarian insufficiency (POI) presents a significant challenge to women's health, with significant implications both physically and emotionally. Despite its life-altering impact, there remain substantial unknowns in the causes this condition and how to optimally manage its various sequelae While such unknows provide direction for future research, they also underscore the need for clinical guidance. In 2015, under the auspices of ESHRE, a group of experts evaluated the existing best evidence and published the first European guideline on the management of premature ovarian insufficiency. The update of this Guideline was performed in an international collaboration of experts representing American Society for Reproductive Medicine (ASRM), International Menopause Society (IMS), and the Centre for Research Excellence in Women’s Health in Reproductive Life (CRE WHiRL). The recent update of the POI guideline covers 40 clinical questions on diagnosis of the condition, the different sequelae, including musculoskeletal health, cardiovascular health, neurological health, sexual function and general well being, and treatment options, including hormone therapy. The list of clinical questions was expanded from the questions included in the guideline from 2015. Based on a scoping survey and appreciation of emerging knowledge of POI, questions were added on the role of AMH in the diagnosis of POI, fertility preservation, muscle health, and specific considerations for hormone treatment in iatrogenic POI. Additionally, the topic on complementary treatments was extended with specific focus on non-hormonal treatments and lifestyle management options. The draft guideline published for stakeholder review includes a total of 142 recommendations. One third of these recommendations were formulated as good practice points. Of the evidence-based recommendations, almost 80% were formulated as strong recommendations, even if the evidence base for most evidence-based recommendations was limited to observational data (level very low or low), supporting a call for future research. The guideline group hope that the new POI Guideline will improve the clinical management of this devastating condition.